Alveolar fibrin formation caused by enhanced procoagulant and depressed fibrinolytic capacities in severe pneumonia: Comparison with the acute respiratory distress syndrome

American Journal of Respiratory and Critical Care Medicine

Volumn 161, Issue 2 I, 2000, Pages 454-462

  Günther, Andreas ^a   Mosavi, Parvin ^a   Heinemann, Sabine ^a   Ruppert, Clemens ^a   Muth, Heidi ^a   Markart, Philipp ^a   Grimminger, Friedrich ^a   Walmrath, Dieter ^a   Temmesfeld Wollbrück, Bettina ^a   Seeger, Werner ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ANTIPLASMIN; ALTEPLASE; FIBRIN; FIBRINOPEPTIDE A; FIBRINOPEPTIDE D; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROCOAGULANT; UNCLASSIFIED DRUG; UROKINASE;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FIBRIN FORMATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PNEUMONIA; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS;

EID: 0343158249     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.161.2.9712038     Document Type: Article

References (37)

1. Mark, E. 1984. Alveolar disease. In E. J. Mark, editor. Lung Biopsy Interpretation. Williams and Wilkins, Baltimore, MD. 103-112.
2. Hernandez-Rodriguez, N. A., A. D. Chambrey, H. K. Harrison, R. C. Chambers, A. J. Gray, A. M. Southcott, R. du Bois, C. M. Black, M. F. Scully, R. J. Anulty, and G. J. Laurent. 1995. Role of thrombin in pulmonary fibrosis. Lancet 346:1071-1073.
3. Senior, R. M., W. F. Skogen, G. L. Griffin, and G. D. Wilner. 1986. Effects of fibrinogen derivatives upon the inflammatory response: studies with human fibrinopeptide B. J. Clin. Invest. 77:1014-1019.
4. Leavell, K. J., M. W. Peterson, and T. J. Gross. 1996. The role of fibrin degradation products in neutrophil recruitment to the lung. Am. J. Respir. Cell Mol. Biol. 14:53-60.
5. Gray, A. J., J. E. Bishop. J. T. Reeves, R. P. Mecham, and G. J. Laurent. 1995. Partially degraded fibrin(ogen) stimulates fibroblast proliferation in vitro. Am. J. Respir. Mol. Cell Biol. 12:684-690.
6. Ge, M., G. Tang, T. J. Ryan, and A. B. Malik. 1992. Fibrinogen degradation product fragment D induces endothelial cell detachment by activation of cell-mediated fibrinolysis. J. Clin. Invest. 90:2508-2516.
7. Dang, C. V., W. R. Bell, D. Kaiser, and A. Wong. 1985. Disorganization of cultured vascular endothelial cell monolayers by fibrinogen fragment D. Science 227:1487-1490.
8. Seeger, W., A. Elssner, A. Günther, H.-J. Krämer, and H. O. Kalinowski. 1993. Lung surfactant phospholipids associate with polymerizing fibrin: loss of surfactant activity. Am. J. Respir. Cell Mol. Biol. 9:213-220.
9. Günther, A., M. Kalinowski, A. Elssner, and W. Seeger. 1994. Clot-embedded natural surfactant: kinetics of fibrinolysis and surface activity. Am. J. Physiol. 267:L618-L624.
10. Günther, A., M. Kalinowski, S. Rosseau, and W. Seeger. 1995. Surfactant incorporation markedly alters mechanical properties of a fibrin clot. Am. J. Respir. Cell Mol. Biol. 13:712-718.
11. Burkhardt, A. 1989. Alveolitis and collapse in the pathogenesis of pulmonary fibrosis. Am. Rev. Respir. Dis. 140:513-524.
12. Idell, S., K. K. James, E. G. Levin, B. S. Schwartz, N. Manchanda, R. J. Maunder, T. R. Martin, J. McLarty, and D. S. Fair. 1989. Local abnormalities in coagulation and fibrinolytyic pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndrome. J. Clin. Invest. 84:695-705.
13. Idell, S., K. B. Koenig, D. S. Fair, T. R. Martin, J. McLarty, and R. J. Maunder. 1991. Serial abnormalities of fibrin turnover in evolving adult respiratory distress syndrome. Am. J. Physiol. 261:L240-L248.
14. Fuchs-Buder, T., P. de Moerloose, B. Ricou, G. Reber, C. Vifian, L. Nicod, J.-A. Romand, and P. M. Suter. 1996. Time course of procoagulant activity and D-dimer in bronchoalveolar fluid of patients at risk for or with acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 153:163-167.
15. Seeger, W., J. Hübel, K. Klapettek, U. Pison, U. Obertacke, T. Joka, and L. Roka. 1991. Procoagulant activity in bronchoalveoar lavage of severly traumatized patients: relation to the development of acute respiratory distress. Thromb. Res. 91:45-52.
16. Bertozzi, P., B. Astedt, L. Zenzius, K. Lynch, F. LeMaire, W. Zapol, Jr., and H. A. Chapman. 1990. Depressed bronchoalveolar urokinase activity in patients with adult respiratory distress syndrome. N. Engl. J. Med. 322:890-897.
17. Sloane, P. J., M. H. Gee, J. E. Gottlieb, K. H. Albertine, S. P. Peters, J. R. Burns, G. Maciedo, and J. E. Fish. 1992. A multicenter registry of patients with acute respiratory distress syndrome. Am. Rev. Respir. Dis. 146:419-426.
18. Bernard, G. R., A. Artigas, K. L. Brigham, J. Carlet, K. Falkc, L. Hudson, M. Lamy, J. R. Legall, A. Morris, R. Spragg, and the Consensus Committee. 1994. The American-European Consensus Conference on ARDS. Am. J. Respir. Crit. Care Med. 149:818-824.
19. Günther, A., C. Siebert, R. Schmidt, S. Ziegler, F. Grimminger, M. Yabut, B. Temmesfeld, D. Walmrath, H. Morr, and W. Seeger. 1996. Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edema. Am. J. Respir. Crit. Care Med. 153:176-184.
20. McGee, M. P., and H. Rothberger. 1985. Tissue factor in bronchoalveolar lavage fluids: evidence for an alveolar macrophage source. Am. Rev. Respir. Dis. 131:331-336.
21. McGee, M. P., and H. Rothberger. 1986. Assembly of the prothrombin activator complex on rabbit alveolar macrophage high-affinity factor Xa receptors: a kinetic study. J. Exp. Med. 164:1902-1914.
22. McGee, M. P., R. Devlin, G. Saluta, and H. Koren. 1990. Tissue factor and factor VII messenger RNAs in human alveolar macrophages: effects of breathing ozone. Blood 75:122-127.
23. Chapman, H. A., C. L. Allen, and O. L. Stone. 1985. Human alveolar macrophages synthezise factor VII in vitro: possible role in interstitial lung disease. J. Clin. Invest. 75:2030-2037.
24. McGee, M. P., R. Wallin, F. B. Wheeler, and H. Rothenberger. 1989. Initiation of the extrinsic pathway of coagulation by human and rabbit alveolar macrophages: a kinetic study. Blood 74:1583-1590.
25. Gross, T. J., R. H. Simon, C. J. Kelly, and R. G. Sitrin. 1991. Rat alveolar epithelial cells concomitantly express plasminogen activator inhibitor-1 and urokinase. Am. J. Physiol. 260:L286-L295.
26. Gross, T. J., R. H. Simon, and R. G. Sitrin. 1992. Tissue factor procoagulant expression by rat alveolar epithelial cells. Am. J. Respir. Cell Mol. Biol. 6:397-403.
27. Gross, T. J., R. H. Simon, and R. G. Sitrin. 1990. Expression of urokinase-type plasminogen activator by rat pulmonary alveolar epithelial cells. Am. J. Respir. Cell Mol. Biol. 3:449-456.
28. Parton, L. A., D. Warbuton, and W. E. Laug. 1992. Plasminogen activator inhibitor type 1 production by rat type II pncumocytes in culture. Am. J. Respir. Cell Mol. Biol. 6:133-139.
29. Idell, S., C. Zwieb, J. Boggaram, D. Holiday, A. R. Johnson, and G. Raghu. 1992. Mechanisms of fibrin formation and lysis by human lung fibroblasts: influence of TGF-β and TNF-α. Am. J. Physiol. 263:L487-L494.
30. Hagood, J. S., M. A. Olman, J. A. Godoy, K. E. Rivera, and G. M. Fuller. 1996. Regulation of type 1 plasminogen activator inhibitor by fibrin degradation products in rat lung fibroblasts. Blood 9:3749-3757.
31. de Benedetti, E., L. Nicod, G. Reber, C. Vifian, and P. de Moerloose. 1992. Procoagulant and fibrinolytic activities in bronchoalveolar fluid of HIV-positive and HIV-negative patients. Eur. Respir. J. 5:411-417.
32. Chapman, H., X. Yang, L. Z. Sailor, and D. J. Sugarbaker. 1990. Developmental expression of plasminogen activator inhibitor type I by human alveolar macrophages. J. Immunol. 145:3398-3405.
33. Chapman, H. A., Jr., and O. Lee Stone. 1985. A fibrinolytic inhibitor of human alveolar macrophages. Am. Rev. Respir. Dis. 132:569-575.
34. Chapman, H. A., Jr., O. Lee Stone, and Z. Vavrin. 1984. Degradation of fibrin and elastin by intact human alveolar macrophages in vitro: characterization of a plasminogen activator and ist role in matrix degradation. J. Clin. Invest. 73:806-815.
35. Ruf, W., and T. S. Edgington. 1994. Structural biology of tissue factor, the initiator of thrombogenesis in vivo. FASEB J. 8:385-390.
36. Walmrath, D., T. Schneider, J. Pilch, F. Grimminger, and W. Seeger. 1993. Aersolized prostacyclin reduces pulmonary artery pressure and improves gas exchange in the adult respiratory distress syndrome. Lancet 342:961-962.
37. Walmrath, D., T. Schneider, J. Pilch, R. Schermuly, F. Grimminger, and W. Seeger. 1995. Effects of aerosolized prostacyclin in severe pneumonia: impact of fibrosis. Am. J. Respir. Crit. Care Med. 151:724-730.